Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Temporal predictors of SARS-CoV-2 antibodies

Researchers in a recent paper published as a preprint on the preprint medRxiv, study the clinical factors, the laboratory assays to streamline plasma donor selection, and the durability of nAb responses in adults.

11 Oct 2020

New study reports on extremely potent human monoclonal antibodies for SARS-CoV-2

Researchers have recovered and identified the various types of neutralizing antibodies for SARS-CoV-2 from convalescent COVID-19 patients. Of these, they identified three that are extremely potent and could be used to develop treatment therapies.

11 Oct 2020

Vaccines likely to be effective against SARS-CoV-2 D614G mutation

The emergence of the new severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) mutation D614G has raised many questions, including whether it will cause the virus to become resistant to the vaccines produced against earlier versions of the virus. A new study published in the journal npj Vaccines in October 2020 shows that this may be an unfounded fear.

11 Oct 2020

Rapid and sensitive detection of SARS-CoV-2 with functionalized magnetic nanoparticles

A recent study published on the preprint server arXiv in October 2020 shows the potential for using functionalized magnetic nanoparticles to detect the presence of the virus in a sample.

11 Oct 2020

Analysis of existing comorbidities and COVID-19 mortality

As the COVID-19 pandemic continues to spread, and research related to potential risk factors for COVID-19 mortality continues, it is becoming clear that individuals with underlying comorbidities have a greater risk of death from COVID-19. The exact contribution of different comorbidities is unclear, however. Now, a new study published in the journal PLOS ONE dissects this topic and may help to quantify the risk posed by specific conditions and offer help with the prognosis.

11 Oct 2020

Pathways contributing to hypercoagulability in severe SARS‐CoV‐2 patients

In a study by researchers explored the possible mechanisms of the clotting disorder, focusing on the role of hypoxia-related activation of coagulation factors; cytokine storm, activation of neutrophils, and the release of neutrophil extracellular traps.

11 Oct 2020

Fetal brain models could predict neurodevelopmental outcomes of COVID-19 exposure

Researchers in the United States and Sweden have created personalized models of fetal brain microglia to investigate the effects of maternal infection on the developing brain, including infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) – the agent that causes coronavirus disease 2019 (COVID-19).

11 Oct 2020

New age and sex-specific model of COVID-19 transmission

Researchers at the University of Rostock in Germany have developed a model of coronavirus disease 2019 (COVID-19) transmission that considers subdivisions of age and sex to provide better insights into the impact that increased contact rates might have on the risk of infection and mortality.

11 Oct 2020

Exciting findings on CD8 T cell response in recovered COVID patients

An international team of scientists has identified novel T cell-recognized epitopes spanning different proteins of severe acute respiratory syndrome coronavirus 2 in COVID-19 recovered patients. The scientists have also revealed phenotypical characteristics of the T cell population.

11 Oct 2020

Ottawa Public Health receiving new metric to help measure COVID-19 levels in wastewater

Ottawa Public Health is receiving new metric to help measure levels of COVID-19 in the community: wastewater.

9 Oct 2020

Study compares the effect of hydroxychloroquine versus favipiravir in SARS-CoV-2−infected hamsters

Virologists at the Rega Institute have shown that the anti-malaria drug hydroxychloroquine does not limit SARS-CoV-2 coronavirus replication in hamsters.

9 Oct 2020

Antibody cocktail may offer clinical benefit in both prevention and treatment of COVID-19

In June, two studies in Science reported an antibody cocktail against SARS-CoV-2 developed from studies in humanized mice and recovering patients. The two antibody cocktail was designed to bind the virus to reduce the risk of a drug-resistant form emerging.

9 Oct 2020

Serum antibodies from SARS-CoV patients effectively neutralized SARS-CoV-2 in cultured cells

Antibodies in serum samples collected from patients infected with SARS-CoV during the 2003 outbreak effectively neutralized SARS-CoV-2 infection in cultured cells, according to a new study.

9 Oct 2020

Exuberant activation of immune cells in severe COVID-19 resembles lupus

In severe cases of COVID-19, Emory researchers have been observing an exuberant activation of immune cells, resembling acute flares of systemic lupus erythematosus (SLE), an autoimmune disease.

9 Oct 2020

COVID-19-related social distancing measures reduce noise exposure nearly in half

People's exposure to environmental noise dropped nearly in half during the early months of the coronavirus pandemic, according to University of Michigan researchers who analyzed data from the Apple Hearing Study.

9 Oct 2020

Over $1 million CIHR funding for six uOttawa COVID-19 mental health projects

Six University of Ottawa-affiliated projects focusing on COVID-19's impact on mental health have won important funding grants totaling over $1 million from the Canadian Institutes of Health Research (CIHR).

9 Oct 2020

As Trump touts his ‘great’ COVID drugs, the pharma cash flows to Biden, not him

Pharmaceutical giants Regeneron and Gilead Sciences got the kind of publicity money can't buy this week after President Donald Trump took their experimental drugs for his coronavirus infection, left the hospital and pronounced himself fully recovered.

9 Oct 2020

Researchers receive €2.35 million to examine disease pathways of viruses

Two University College Dublin (UCD) researchers and SiriusXT, a UCD spin-out company, have been awarded a total of €2.35 million in funding for a disruptive photonics technology project, through Horizon 2020, the EU's research and innovation programme, to examine the disease pathways of viruses.

9 Oct 2020

New study examines relationship between ethnic background and SARS-CoV-2 virus

Patients of Black ethnicity have an increased risk of requiring hospital admission for COVID-19, while patients of Asian ethnicity have an increased risk of dying in hospital from COVID-19, compared to White patients, a study has found.

9 Oct 2020

Long-lasting antibodies detected in blood and saliva of COVID-19 patients

Two separate studies have documented the persistence of antibodies that target SARS-CoV-2 in hundreds of patients with COVID-19 at least 3 months after symptom onset.

9 Oct 2020

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Temporal predictors of SARS-CoV-2 antibodies

New study reports on extremely potent human monoclonal antibodies for SARS-CoV-2

Vaccines likely to be effective against SARS-CoV-2 D614G mutation

Rapid and sensitive detection of SARS-CoV-2 with functionalized magnetic nanoparticles

Analysis of existing comorbidities and COVID-19 mortality

Pathways contributing to hypercoagulability in severe SARS‐CoV‐2 patients

Fetal brain models could predict neurodevelopmental outcomes of COVID-19 exposure

New age and sex-specific model of COVID-19 transmission

Exciting findings on CD8 T cell response in recovered COVID patients

Ottawa Public Health receiving new metric to help measure COVID-19 levels in wastewater

Study compares the effect of hydroxychloroquine versus favipiravir in SARS-CoV-2−infected hamsters

Antibody cocktail may offer clinical benefit in both prevention and treatment of COVID-19

Serum antibodies from SARS-CoV patients effectively neutralized SARS-CoV-2 in cultured cells

Exuberant activation of immune cells in severe COVID-19 resembles lupus

COVID-19-related social distancing measures reduce noise exposure nearly in half

Over $1 million CIHR funding for six uOttawa COVID-19 mental health projects

As Trump touts his ‘great’ COVID drugs, the pharma cash flows to Biden, not him

Researchers receive €2.35 million to examine disease pathways of viruses

New study examines relationship between ethnic background and SARS-CoV-2 virus

Long-lasting antibodies detected in blood and saliva of COVID-19 patients

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Coronavirus Disease COVID 19 News and Research

Latest Coronavirus Disease COVID 19 News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in